Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution EP News Bureau Jul 23, 2024 According to IQVIA, the product had US sales of approximately $ 153 million for the twelve months ended December 2023
Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent EP News Bureau Jul 9, 2024 The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolensa Ophthalmic Solution, 0.07 per…
Lupin Appoints Johnny Mikell as Global Head of Quality EP News Bureau Oct 3, 2019 Johnny will be based out of Lupin’s US offices and will lead the Company’s Quality function globally
Alembic Pharma gets US FDA nod for ophthalmic solution Press Trust of India Jun 24, 2019 The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 per cent,…